Tesamorelin vs CJC/Ipa for visceral fat, anyone compared directly?

Posted by busy_mom in GH & Growth Peptides - 1 points, 1 comments.

I have been digging into tesamorelin lately, partly because the visceral fat reduction data is actually impressive (up to 18% in the HIV lipodystrophy trials, and it is FDA-approved there, which is rare for this category). What caught my attention is that it seems more targeted than the usual CJC-1295/Ipa stack for the deep abdominal fat I would like to lose.

The combination profile on here describes tesamorelin plus ipa as producing a synergistic pulse, with the GHRH plus GHRP pairing giving a bigger GH response than either alone. That makes sense mechanistically since they hit different receptors. For those who have run both, a pure tesamorelin run and a tesa/ipa combo, did you notice a meaningful difference in body composition, or did it feel mostly the same to you?

Also curious about the practical side. Tesamorelin has a very short half-life (around 26-38 minutes) so timing the injection before bed seems to matter for catching the natural sleep pulse. Did bedtime work better for you than morning, or the opposite? And did anyone see water retention or joint aches that pushed them to lower the dose?

I am trying to design a focused 12-week run and would appreciate real feedback before I commit.

Comments

• elle774: Interesting, tbh I never stacked them, I only ran tesamorelin for 16 weeks on its own so I can't really speak to the combo part. For visceral fat though, yes I did see something, my waist measurement came down noticeably, more than what the scale was showing, which fits the pattern that it's hitting visceral and not so much subcutaneous. Took about 6-8 weeks before I could see it on the tape. Bedtime was way better for me. When I tried morning I just felt weird and kind of tired during the day
• busy_mom: The waist dropping more than the weight is a really useful datapoint, since that suggests the loss is happening where I would want it (deep abdominal) rather than the more visible subcutaneous layer. The 6-8 week onset is consistent with what I have seen in the trials too, so that gives me a reasonable expectation to set. Interesting that you found bedtime clearly better, I was wondering if the pulsatile pattern matters that much in practice or if it is more theoretical. Did you do anything sp
• busy_mom: Thanks for the actual numbers, that 6-8 week window is useful because I keep reading conflicting timelines. The waist vs scale discrepancy is also consistent with what I would expect mechanistically since visceral fat has a higher turnover than subcutaneous, so it shows up on the tape first. Could I ask what your dose was and whether you titrated up, or stayed flat the whole 16 weeks? I am trying to figure out if a steady dose is enough or if most people ramp.

Community discussion - research and educational context only. Not medical advice.